Housey Healthcare ULC
HP-211
Type 2 Diabetes
Countdown
117days
Phase 2 readout · ~ Oct 31, 2026 estimated
What's at stake
Phase 2 trial results for HP-211 in Type 2 Diabetes are due ~ Oct 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 13h ago
“CT.gov NCT07546929: Phase 2 trial, sponsor Housey Healthcare ULC, drug HP-211. Primary completion date 2026-10 (estimated).”